These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8590774)

  • 1. Factor VIII inhibitor developed in a 60-year-old patient with mild hemophilia A after surgery for colon cancer.
    Suzuki T; Arai M; Miyasaka S; Watanabe J; Sugimura D; Amano K; Yamagishi T; Kagawa K; Fukue H; Fukutake K
    Int J Hematol; 1995 Aug; 62(2):127-32. PubMed ID: 8590774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophilia and von Willebrand's disease: 2. Management. Association of Hemophilia Clinic Directors of Canada.
    CMAJ; 1995 Jul; 153(2):147-57. PubMed ID: 7600466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E; Morfini M; Rocino A; Baudo F; Scaraggi FA; Gringeri A
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A.
    Peyvandi F; Mannucci PM; Garagiola I; El-Beshlawy A; Elalfy M; Ramanan V; Eshghi P; Hanagavadi S; Varadarajan R; Karimi M; Manglani MV; Ross C; Young G; Seth T; Apte S; Nayak DM; Santagostino E; Mancuso ME; Sandoval Gonzalez AC; Mahlangu JN; Bonanad Boix S; Cerqueira M; Ewing NP; Male C; Owaidah T; Soto Arellano V; Kobrinsky NL; Majumdar S; Perez Garrido R; Sachdeva A; Simpson M; Thomas M; Zanon E; Antmen B; Kavakli K; Manco-Johnson MJ; Martinez M; Marzouka E; Mazzucconi MG; Neme D; Palomo Bravo A; Paredes Aguilera R; Prezotti A; Schmitt K; Wicklund BM; Zulfikar B; Rosendaal FR
    N Engl J Med; 2016 May; 374(21):2054-64. PubMed ID: 27223147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab for the treatment of high titre inhibitors in mild haemophilia A.
    Dolničar MB; Rajić V; Kitanovski L; Debeljak M
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s345-7. PubMed ID: 23522890
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient factor VIII inhibitor in a hemophilia patient after staphylococcal septic shock syndrome.
    Yamamoto K; Niiya K; Shigematu T; Kiguchi T; Takenaka K; Shinagawa K; Ishimaru F; Ikeda K; Shima M; Harada M
    Int J Hematol; 2000 Dec; 72(4):517-9. PubMed ID: 11197224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.
    Gringeri A; Santagostino E; Mannucci PM
    Haemostasis; 1991; 21(1):1-4. PubMed ID: 1907588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group.
    Schwartz RS; Abildgaard CF; Aledort LM; Arkin S; Bloom AL; Brackmann HH; Brettler DB; Fukui H; Hilgartner MW; Inwood MJ
    N Engl J Med; 1990 Dec; 323(26):1800-5. PubMed ID: 2123300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prostate carcinoma associated spontaneous factor VIII:C inhibitor hemophilia. Successful therapy of severe hemorrhagic complication with porcine factor VIII in a 75-year-old patient].
    Orth T; Schnütgen M; Herr W; Mayet WJ; Dippold W; Wanitschke R; Meyer zum Buschenfelde KH
    Med Klin (Munich); 1997 Apr; 92(4):241-5. PubMed ID: 9221309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation.
    Thompson AR; Murphy ME; Liu M; Saenko EL; Healey JF; Lollar P; Scandella D
    Blood; 1997 Sep; 90(5):1902-10. PubMed ID: 9292523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor.
    Carr ME; Loughran TP; Cardea JA; Smith WK; Kuhn JG; Dottore MV
    Int J Hematol; 2002 Jan; 75(1):95-9. PubMed ID: 11843300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful peritoneal dialysis in a hemophilia A patient with factor VIII inhibitor.
    Solak Y; Turkmen K; Atalay H; Turk S
    Perit Dial Int; 2010; 30(1):114-6. PubMed ID: 20056993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.
    Lusher JM; Arkin S; Abildgaard CF; Schwartz RS
    N Engl J Med; 1993 Feb; 328(7):453-9. PubMed ID: 8421474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
    Biron-Andréani C; Dupeyron G; Mainemer M; Schved JF
    Blood Coagul Fibrinolysis; 2001 Apr; 12(3):215-6. PubMed ID: 11414637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lingual hemorrhage in a patient with hemophilia A complicated by a high titer inhibitor. Management by continuous infusion of monoclonal antibody-purified factor VIII.
    Gordon EM; Mungo R; Goldsmith JC
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):107-10. PubMed ID: 8447550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.
    Calvez T; Chambost H; d'Oiron R; Dalibard V; Demiguel V; Doncarli A; Gruel Y; Huguenin Y; Lutz P; Rothschild C; Vinciguerra C; Goudemand J;
    Haematologica; 2018 Jan; 103(1):179-189. PubMed ID: 29025913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A close insight to factor VIII inhibitor in the congenital hemophilia A.
    Tabriznia-Tabrizi S; Gholampour M; Mansouritorghabeh H
    Expert Rev Hematol; 2016 Sep; 9(9):903-13. PubMed ID: 27367203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization.
    Collins PW; Chalmers E; Hart DP; Liesner R; Rangarajan S; Talks K; Williams M; Hay CR;
    Br J Haematol; 2013 Jan; 160(2):153-70. PubMed ID: 23157203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.